A Different Approach to Preventing Thrombosis

NCT02774265 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

329

Enrollment

OTHER

Sponsor class

Conditions

Venous Thromboembolism
Pulmonary Embolism

Interventions

DRUG: VTE prophylaxis with Enoxaparin 30mg BID
DRUG: VTE prophylaxis with Aspirin 81mg BID

Sponsor

University of Maryland, Baltimore